Sec. 1369.654.  PROHIBITION ON MULTIPLE PRIOR AUTHORIZATIONS.  (a)  A health benefit plan issuer that provides prescription drug benefits may not require an enrollee to receive more than one prior authorization annually of the prescription drug benefit for a prescription drug prescribed to treat an autoimmune disease, hemophilia, or Von Willebrand disease.
(b)  This section does not apply to:
(1)  opioids, benzodiazepines, barbiturates, or carisoprodol;
(2)  prescription drugs that have a typical treatment period of less than 12 months;
(3)  drugs that:
(A)  have a boxed warning assigned by the United States Food and Drug Administration for use; and
(B)  must have specific provider assessment; or
(4)  the use of a drug approved for use by the United States Food and Drug Administration in a manner other than the approved use.
Added by Acts 2023, 88th Leg., R.S., Ch. 669 (H.B. 755), Sec. 1, eff. September 1, 2023.